# PET-Plan (NCT00697333)

> Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: inoperable locally advanced non-small-cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00697333
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN
- Conditions: Non-small Cell Lung Cancer
- Interventions: restriction of radiotherapy to FDG-PET positive areas only
- Enrollment: 200
- Primary outcome: time to local progression

## Indexed commentary on PET-Plan so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 6 posts on X
- 1 podcast episode

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=pet-plan-nct00697333